---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-023048"
form_type: "8-K"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T04:58:35.057218+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DiaMedica raises $30.1M via private placement of 8.6M shares at $3.50 to fund preeclampsia pipeline

## Summary
- Private placement of 8,606,426 common shares at $3.50 per share, raising $30.1M gross proceeds.
- Closing expected July 23, 2025; no placement agent engaged.
- Proceeds to support DM199 IND submission and Phase 2b study for preeclampsia and fetal growth restriction.
- Registration rights agreement requires filing resale registration statement within 10 business days of closing.
- Transaction involves non-management related parties; exempt from Canadian MI 61-101 valuation/minority approval.

## SEC filing metadata
- accession: 0001437749-25-023048
- form_type: 8-K
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774925023048/0001437749-25-023048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774925023048/dmtp20250720_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-023048
- JSON: https://secwatch.observer/filing/0001437749-25-023048.json
- Plain text: https://secwatch.observer/filing/0001437749-25-023048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.